Buscar en
Porto Biomedical Journal
Toda la web
Inicio Porto Biomedical Journal Most often read
Journal Information

Most often read

30607
Melkersson-Rosenthal syndrome – delay in the diagnosis of an early-onset oligosymptomatic variant
Fabrícia Carolino, Margarida Fernandes, José Luís Plácido
Porto Biomed J. 2016;1:43-5
30607
Open access
21779
Pulsed electromagnetic field therapy effectiveness in low back pain: A systematic review of randomized controlled trials
Renato Andrade, Hugo Duarte, Rogério Pereira, Isabel Lopes, Hélder Pereira, Rui Rocha, João Espregueira-Mendes
Porto Biomed J. 2016;1:156-63
21779
Open access
17817
The PD-1:PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives
Rui Silva, Irene Gullo, Fátima Carneiro
Porto Biomed J. 2016;1:4-11
17817
Open access
16600
Communication skills in medical students – An exploratory study before and after clerkships
Isabel Taveira-Gomes, Rui Mota-Cardoso, Margarida Figueiredo-Braga
Porto Biomed J. 2016;1:173-80
16600
Open access
16477
The impact of folic acid supplementation on gestational and long term health: Critical temporal windows, benefits and risks
Carla Silva, Elisa Keating, Elisabete Pinto
Porto Biomed J. 2017;2:315-32
16477
Highlights

  • Associations between FA supplementation in pregnancy and effects on offspring's NTDs, allergy/respiratory problems, cancer and behaviour problems as been studied.

  • There is growing concern about the effects of excessive FA supplementation, whether in terms of doses or times of exposure.

  • FA supplementation in the periconceptional period is protective against NTDs while in later periods it could be deleterious.

  • A daily dose of 0.4mg FA in the periconceptional period seems to be effective and safe.

Open access
12722
Comparison between effects of antibiotics, NSAIDs and their mixture on the growth of microorganisms
S. Bhattacharya, Y. Akula, G.M. Mitongo, Q. Khorram
Porto Biomed J. 2017;2:176-7
12722
Open access
10610
Rituximab in generalized myasthenia gravis: Clinical, quality of life and cost–utility analysis
João Peres, Rita Martins, José Delgado Alves, Ana Valverde
Porto Biomed J. 2017;2:81-5
10610
Highlights

  • Rituximab use in MG patients lead to the reduction of relapses and to a lesser use of immunosuppressive agents in our series.

  • Rituximab use in our MG patients decreased healthcare costs after treatment, comparing to the pre-treatment period.

  • Rituximab is a clinical effective treatment for B cell-related diseases like MG and seems to be a cost–saving intervention.

Open access
10039
The importance of outdoor play for young children's healthy development
Gabriela Bento, Gisela Dias
Porto Biomed J. 2017;2:157-60
10039
Open access
9110
Probiotics for the control of obesity – Its effect on weight change
Ana Lídia Rouxinol-Dias, Ana Raquel Pinto, Catarina Janeiro, Daniel Rodrigues, Marta Moreira, João Dias, Pedro Pereira
Porto Biomed J. 2016;1:12-24
9110
Open access
9067
Cognitive and emotional impairments in obsessive–compulsive disorder: Evidence from functional brain alterations
Óscar F. Gonçalves, Sandra Carvalho, Jorge Leite, Ana Fernandes-Gonçalves, Angel Carracedo, Adriana Sampaio
Porto Biomed J. 2016;1:92-105
9067
Open access
7750
Botulinum toxin improves pain in chronic anal fissure
Hugo Amorim, José Santoalha, Rui Cadilha, Maria-José Festas, Paula Barbosa, Armanda Gomes
Porto Biomed J. 2017;2:273-6
7750
Highlights

  • Chronic anal fissure is a common condition associated with intense pain.

  • Local botulinum toxin injection is a valid option in its management.

  • Pain intensity scores significantly improved after BoNT injection.

  • Side effects were rare and mild.

  • Our results support the inclusion of BoNT in the management algorithm of chronic anal fissure.

Open access
7438
Regulation of colonic epithelial butyrate transport: Focus on colorectal cancer
Pedro Gonçalves, Fátima Martel
Porto Biomed J. 2016;1:83-91
7438
Highlights

  • Fermentation of the dietary fiber by intestinal microflora results in production of butyrate.

  • Butyrate possesses anticarcinogenic effect at the colonic level.

  • Three transporters (MCT1, SMCT1 and BCRP) regulate the intracellular concentration of BT in colonic epithelial cells.

  • Changes in the expression of these transporters occur in colorectal cancer.

Open access
7376
Congenital dacryocystocele in infant: A rare cause of eye swelling
Fábio Barroso, Renato Silva, Catarina Mendes
Porto Biomed J. 2017;2:28-9
7376
Open access
7240
Reversible cerebral vasoconstriction syndrome – A narrative revision of the literature
Laura Santos, Elsa Azevedo
Porto Biomed J. 2016;1:65-71
7240
Open access
6922
“Non-resolving pneumonia”: A case of cryptogenic organizing pneumonia
Pedro Pinto-Lopes, André Santos Silva, Joana Pimenta
Porto Biomed J. 2016;1:191-2
6922
Open access
6889
Role of platelets in immune system and inflammation
Ozge Sonmez, Mehmet Sonmez
Porto Biomed J. 2017;2:311-4
6889
Open access
6868
Family physicians’ opinions on and difficulties with breaking bad news
José António Ferraz Gonçalves, Carla Almeida, Joana Amorim, Rita Baltasar, Joana Batista, Yusianmar Borrero, João Pedro Fallé, Igor Faria, Manuel Henriques, Helena Maia, Teresa Fernandes, Mariana Moreira, Susana Moreira, Camila Neves, Ana Ribeiro, Ana Santos, Filipa Silva, Susana Soares, Cristina Sousa, Joana Vicente, Rita Xavier
Porto Biomed J. 2017;2:277-81
6868
Highlights

  • Breaking bad news is still deemed a difficult task by family physicians.

  • Family physicians feel they need training in breaking bad news.

  • The family physicians’ attitude to this issue is different from what they would wish if they themselves had a life-threatening disease.

Open access
6665
The effects of cannabinoids in exemestane-resistant breast cancer cells
C. Almeida, T. Augusto, G. Correia-da-Silva, N. Teixeira, C. Amaral
Porto Biomed J. 2017;2:221-2
6665
Open access
6366
Public and patient participation in health policy, care and research
Cláudia de Freitas
Porto Biomed J. 2017;2:31-2
6366
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos